Computational analysis of cancer genome sequencing data DOI
Isidro Cortés‐Ciriano, D. Gulhan, Jake June-Koo Lee

и другие.

Nature Reviews Genetics, Год журнала: 2021, Номер 23(5), С. 298 - 314

Опубликована: Дек. 8, 2021

Язык: Английский

A compendium of mutational cancer driver genes DOI
Francisco Martínez-Jiménez, Ferran Muiños, Inés Sentís

и другие.

Nature reviews. Cancer, Год журнала: 2020, Номер 20(10), С. 555 - 572

Опубликована: Авг. 10, 2020

Язык: Английский

Процитировано

1018

Mechanisms of APOBEC3 mutagenesis in human cancer cells DOI Creative Commons
Mia Petljak, Alexandra Dananberg, Kevan Chu

и другие.

Nature, Год журнала: 2022, Номер 607(7920), С. 799 - 807

Опубликована: Июль 20, 2022

The APOBEC3 family of cytosine deaminases has been implicated in some the most prevalent mutational signatures cancer1-3. However, a causal link between endogenous enzymes and human cancer genomes not established, leaving mechanisms mutagenesis poorly understood. Here, to investigate mutagenesis, we deleted genes from cell lines that naturally generate APOBEC3-associated over time4. Analysis non-clustered clustered across whole-genome sequences 251 breast, bladder lymphoma line clones revealed APOBEC3A deletion diminished signatures. Deletion both APOBEC3B further decreased mutation burdens, without eliminating them. increased protein levels, activity APOBEC3A-mediated lines. uracil glycosylase UNG was required for APOBEC3-mediated transversions, whereas loss translesion polymerase REV1 overall burdens. Together, these data represent direct evidence cells. Our results identify as main driver mutations, indicate can restrain APOBEC3A-dependent while contributing its own smaller burdens dissect translate activities into distinct

Язык: Английский

Процитировано

184

Functions and consequences of AID/APOBEC-mediated DNA and RNA deamination DOI Creative Commons
Riccardo Pecori, Salvatore Di Giorgio, Jose Paulo Lorenzo

и другие.

Nature Reviews Genetics, Год журнала: 2022, Номер 23(8), С. 505 - 518

Опубликована: Март 7, 2022

The AID/APOBEC polynucleotide cytidine deaminases have historically been classified as either DNA mutators or RNA editors based on their first identified nucleic acid substrate preference. can generate functional diversity at antibody genes but also cause genomic instability in cancer. informational the transcriptome of innate immune cells, and cancer cells. Members both classes act antiviral restriction factors. Recent structural work has illuminated differences similarities between enzymes that catalyse mutation, editing both, suggesting strict classification members this family should be reconsidered. As many these employed for targeted genome (or transcriptome) editing, a more holistic understanding will help improve design therapeutically relevant programmable base editors. In Perspective, Pecori et al. provide an overview deaminase family, discussing key features, how they contribute to viral tumour evolution harnessed (potentially therapeutic) base-editing purposes.

Язык: Английский

Процитировано

180

CRISPR-based genome editing through the lens of DNA repair DOI Creative Commons

Tarun S. Nambiar,

Lou Baudrier,

Pierre Billon

и другие.

Molecular Cell, Год журнала: 2022, Номер 82(2), С. 348 - 388

Опубликована: Янв. 1, 2022

Язык: Английский

Процитировано

157

APOBEC: A molecular driver in cervical cancer pathogenesis DOI Open Access

Sundaramoorthy Revathidevi,

Avaniyapuram Kannan Murugan, Hirofumi Nakaoka

и другие.

Cancer Letters, Год журнала: 2020, Номер 496, С. 104 - 116

Опубликована: Окт. 7, 2020

Язык: Английский

Процитировано

154

Clinical cancer genomic profiling DOI
Debyani Chakravarty, David B. Solit

Nature Reviews Genetics, Год журнала: 2021, Номер 22(8), С. 483 - 501

Опубликована: Март 24, 2021

Язык: Английский

Процитировано

143

MutationalPatterns: the one stop shop for the analysis of mutational processes DOI Creative Commons
Freek Manders, Arianne M. Brandsma, Jurrian K. de Kanter

и другие.

BMC Genomics, Год журнала: 2022, Номер 23(1)

Опубликована: Фев. 15, 2022

The collective of somatic mutations in a genome represents record mutational processes that have been operative cell. These can be investigated by extracting relevant patterns from sequencing data.

Язык: Английский

Процитировано

124

Mapping clustered mutations in cancer reveals APOBEC3 mutagenesis of ecDNA DOI Creative Commons
Erik N. Bergstrom, Jens Luebeck, Mia Petljak

и другие.

Nature, Год журнала: 2022, Номер 602(7897), С. 510 - 517

Опубликована: Фев. 9, 2022

Clustered somatic mutations are common in cancer genomes and previous analyses reveal several types of clustered single-base substitutions, which include doublet- multi-base substitutions

Язык: Английский

Процитировано

120

Mutational signatures in esophageal squamous cell carcinoma from eight countries with varying incidence DOI
Sarah Moody, S. Senkin, S. M. Ashiqul Islam

и другие.

Nature Genetics, Год журнала: 2021, Номер 53(11), С. 1553 - 1563

Опубликована: Окт. 18, 2021

Язык: Английский

Процитировано

118

Therapy-induced APOBEC3A drives evolution of persistent cancer cells DOI
Hideko Isozaki, Ramin Sakhtemani, Ammal Abbasi

и другие.

Nature, Год журнала: 2023, Номер 620(7973), С. 393 - 401

Опубликована: Июль 5, 2023

Язык: Английский

Процитировано

82